by Dr. Joseph Mercola, Mercola.com
When evaluating the safety of vaccines, adjuvants must be taken into account. The most commonly used vaccine adjuvant is aluminum, a demonstrated neurotoxin that is added to certain vaccines to increase your immune response and, with that, theoretically a higher response of protective antibodies.
Despite aluminum’s known health risks, it’s widely suggested that aluminum in vaccines is safe, including for newborn babies, but a math error in a key US Food and Drug Administration study — revealed by scientists at Physicians for Informed Consent (PIC) — raises new safety concerns.
When the aluminum adjuvant was first approved for use in vaccines more than 90 years ago, it was approved based on demonstration of efficacy — safety studies weren’t performed. A 2002 document from the FDA even states:
“Historically, the non-clinical safety assessment for preventive vaccines has often not included toxicity studies in animal models. This is because vaccines have not been viewed as inherently toxic, and vaccines are generally administered in limited dosages over months or even years.”
That being said, in 2002, researchers with the US Centers for Disease Control and Prevention’s Agency for Toxic Substances and Disease Registry (ATSDR) released a study on the effect of medical aluminum exposure on public health in order to estimate the infant body burden of aluminum in infants following a standard vaccination schedule during the first year of life.
They found that, while the body burden of aluminum from vaccinations exceeded that from dietary sources, it was still below the minimal risk level established by ATSDR. In 2011, FDA scientists updated the 2002 study with a current pediatric vaccination schedule and other updated parameters, and that is where PIC found what is described as a “crucial math error.”
© 2020 Dr. Joseph Mercola